IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer

RTTNews | hace 1022
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer

(RTTNews) - Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.

Beaupre's extensive career includes various clinical development and translational research roles in industry, including most recently at BioSplice Therapeutics as Chief Medical Officer and Head of Research and Development in Oncology.

Beaupre previously served as Senior Vice President, Head of Early Oncology Development and Clinical Research at Pfizer, Inc., where he led cross-disciplinary groups including clinical development, clinical pharmacology, translational oncology and clinical operations related study clinicians.

Beaupre also served at Pharmacyclics (Abbvie) as Vice President, Head of Early Development and Immunotherapy, and at Amgen as Medical Director.

He was previously an Assistant Professor at the H. Lee Moffitt Cancer Center and Research Institute, and also held various earlier appointments at the University of Miami and the M.D. Anderson Cancer Center.

read more
IDEAYA Biosciences Q4 Results Misses Estimates

IDEAYA Biosciences Q4 Results Misses Estimates

IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
RTTNews | hace 573
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews | hace 756
KOSPI Has Another Positive Lead For Tuesday

KOSPI Has Another Positive Lead For Tuesday

The South Korea stock market has moved higher in 10 straight sessions, surging more than 260 points or 8.3 percent along the way. Now at another fresh record closing high, the KOSPI sits just beneath the 3,410-point plateau and it's tipped to open in the green again on Tuesday.
RTTNews | hace 21 minutos
South Korea Import, Export Price Data Due On Tuesday

South Korea Import, Export Price Data Due On Tuesday

South Korea will on Tuesday see August numbers for import and export prices, highlighting a light day for Asia-Pacific economic activity. In July, import prices were down 5.9 percent on year and export prices fell an annual 4.3 percent.
RTTNews | hace 1h 21min
South Korea Export Prices Rise 0.7% In August

South Korea Export Prices Rise 0.7% In August

Export prices in South Korea were up a seasonally adjusted 0.7 percent on month in August, the Bank of Korea said on Tuesday - after adding 0.8 percent in July.
RTTNews | hace 1h 51min
U.S. Dollar Falls Before Fed Decision

U.S. Dollar Falls Before Fed Decision

The U.S. dollar weakened against its major counterparts in the New York session on Monday, ahead of the Federal Reserve's policy decision on Wednesday.
RTTNews | hace 1h 59min
Swiss Market Ends Weak After Choppy Ride

Swiss Market Ends Weak After Choppy Ride

The Switzerland market ended on a weak note on Monday after spending much of the day's session in negative territory, as investors stayed wary of picking up stocks, choosing to wait for some clear directional clues.
RTTNews | hace 4h 44min
European Markets Close Mostly Higher Ahead Of Central Bank Policy Meetings

European Markets Close Mostly Higher Ahead Of Central Bank Policy Meetings

The markets in Europe closed mostly higher on Monday, although the UK market underperformed and settled slightly lower. Investors digested a batch of regional economic data, and looked ahead to the monetary policy announcements from the Federal Reserve, the Bank of England the Bank of Japan due later in the week.
RTTNews | hace 5h 5min